0.68 - 0.75
0.33 - 0.86
12.80M / 4.66M (Avg.)
35.00 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
18.56%
Positive revenue growth while 0335.HK is negative. John Neff might see a notable competitive edge here.
9.40%
Positive gross profit growth while 0335.HK is negative. John Neff would see a clear operational edge over the competitor.
21.32%
Positive EBIT growth while 0335.HK is negative. John Neff might see a substantial edge in operational management.
21.32%
Operating income growth above 1.5x 0335.HK's 6.68%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
66.19%
Net income growth comparable to 0335.HK's 72.57%. Walter Schloss might see both following similar market or cost trajectories.
67.59%
EPS growth similar to 0335.HK's 63.64%. Walter Schloss would assume both have parallel share structures and profit trends.
67.59%
Similar diluted EPS growth to 0335.HK's 63.64%. Walter Schloss might see standard sector or cyclical influences on both firms.
-0.74%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.67%
Reduced diluted shares while 0335.HK is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-166.08%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-816.18%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
47933.84%
10Y revenue/share CAGR above 1.5x 0335.HK's 276.50%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
1.19%
Positive 5Y CAGR while 0335.HK is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
9.55%
3Y revenue/share CAGR under 50% of 0335.HK's 29.83%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-4802.15%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-181.71%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-137.36%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
387.58%
Below 50% of 0335.HK's 1017.44%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-73.88%
Negative 5Y net income/share CAGR while 0335.HK is 938.86%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-43.89%
Negative 3Y CAGR while 0335.HK is 938.92%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
152.38%
5Y equity/share CAGR 1.25-1.5x 0335.HK's 106.66%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
54.75%
3Y equity/share CAGR at 50-75% of 0335.HK's 81.77%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-87.59%
Negative 5Y dividend/share CAGR while 0335.HK stands at 128.57%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
141.46%
Below 50% of 0335.HK's 300.00%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
24.83%
AR growth of 24.83% while 0335.HK is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
-12.51%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
21.68%
Asset growth 1.25-1.5x 0335.HK's 14.53%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
1.64%
Under 50% of 0335.HK's 13.62%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
281.70%
Debt growth far above 0335.HK's 322.44%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
75.26%
R&D growth of 75.26% while 0335.HK is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
7.69%
SG&A growth well above 0335.HK's 13.53%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.